 |
|
|
| |
TMC435 in patients infected with HCV genotype 1 who have failed previous pegylated interferon / ribavirin treatment: Virologic analyses of the ASPIRE trial
|
| |
| |
Reported by Jules Levin
EASL 2012 April18-22 Barcelona Spain
Oliver Lenz,1Bart Fevery,1Leen Vijgen,1Jannick Verbeeck,1Monika Peeters,1Maria Beumont-Mauviel,1Stefan Zeuzem,2Gaston Picchio3
1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Department of Medicine I, JW Goethe University Hospital, Frankfurt, Germany; 3Janssen Research and Development LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
